健康元
(600380)
| 流通市值：201.97亿 | | | 总市值：201.97亿 |
| 流通股本：18.29亿 | | | 总股本：18.29亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 4,089,279,479.56 | 15,619,480,306.89 | 11,898,828,905.02 | 8,234,634,099.45 |
| 营业收入 | 4,089,279,479.56 | 15,619,480,306.89 | 11,898,828,905.02 | 8,234,634,099.45 |
| 二、营业总成本 | 2,993,038,861.04 | 11,986,201,698.24 | 9,121,682,123.61 | 6,247,787,990.98 |
| 营业成本 | 1,558,416,030.26 | 5,827,852,690.99 | 4,393,919,087.41 | 3,021,125,884.33 |
| 税金及附加 | 48,498,322.81 | 190,409,297.76 | 137,567,242.03 | 93,999,188.76 |
| 销售费用 | 950,570,599.38 | 3,922,967,960.4 | 2,951,059,287.9 | 2,096,637,821.45 |
| 管理费用 | 220,886,435.03 | 911,595,557.28 | 708,729,617.84 | 445,024,332.82 |
| 研发费用 | 300,357,357.53 | 1,435,351,627.65 | 1,036,376,310.06 | 714,729,729.75 |
| 财务费用 | -85,689,883.97 | -301,975,435.84 | -105,969,421.63 | -123,728,966.13 |
| 其中:利息费用 | 22,898,186.53 | 123,261,483.95 | 94,972,898.62 | 72,457,072.68 |
| 其中:利息收入 | 110,971,266.84 | 417,296,591.13 | 245,985,558.7 | 187,438,919.12 |
| 加:公允价值变动收益 | 1,709,488.73 | -17,495,836.34 | -5,736,443.62 | -19,576,467.55 |
| 加:投资收益 | 16,135,173.1 | 64,371,470.73 | 51,650,239.89 | 35,345,305.87 |
| 资产处置收益 | -86,129.77 | 45,262,713.71 | -370,399.04 | -76,440.36 |
| 资产减值损失(新) | -6,355,971.69 | -293,144,305.71 | -113,694,072.7 | -82,185,254.98 |
| 信用减值损失(新) | -8,180,086.41 | -7,262,094.01 | -797,210.83 | -3,873,446.7 |
| 其他收益 | 52,547,543.01 | 191,273,169.08 | 124,184,202.58 | 70,438,830.56 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,152,010,635.49 | 3,616,283,726.11 | 2,832,383,097.69 | 1,986,918,635.31 |
| 加:营业外收入 | 1,173,822.28 | 7,784,838.89 | 6,920,279.4 | 4,941,102.08 |
| 减:营业外支出 | 2,065,905.08 | 49,181,919.67 | 19,988,508.91 | 9,830,386.52 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,151,118,552.69 | 3,574,886,645.33 | 2,819,314,868.18 | 1,982,029,350.87 |
| 减:所得税费用 | 189,994,779.68 | 592,140,657.73 | 385,618,343.11 | 285,813,843.86 |
| 六、净利润 | 961,123,773.01 | 2,982,745,987.6 | 2,433,696,525.07 | 1,696,215,507.01 |
| 持续经营净利润 | 961,123,773.01 | 2,982,745,987.6 | 2,433,696,525.07 | 1,696,215,507.01 |
| 归属于母公司股东的净利润 | 435,788,328.07 | 1,386,570,192.56 | 1,111,560,063.92 | 776,424,466.87 |
| 少数股东损益 | 525,335,444.94 | 1,596,175,795.04 | 1,322,136,461.15 | 919,791,040.14 |
| (一)基本每股收益 | 0.23 | 0.74 | 0.59 | 0.42 |
| (二)稀释每股收益 | 0.23 | 0.74 | 0.59 | 0.42 |
| 八、其他综合收益 | -17,888,787.66 | -8,587,237.01 | -86,688,069.37 | -29,097,306.9 |
| 归属于母公司股东的其他综合收益 | -10,275,802.84 | -10,153,358.01 | -59,369,859.17 | -23,675,110.79 |
| 九、综合收益总额 | 943,234,985.35 | 2,974,158,750.59 | 2,347,008,455.7 | 1,667,118,200.11 |
| 归属于母公司股东的综合收益总额 | 425,512,525.23 | 1,376,416,834.55 | 1,052,190,204.75 | 752,749,356.08 |
| 归属于少数股东的综合收益总额 | 517,722,460.12 | 1,597,741,916.04 | 1,294,818,250.95 | 914,368,844.03 |
| 公告日期 | 2025-04-25 | 2025-04-08 | 2024-10-25 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |